Fig. S4.
Nontransformed and Ras-V12-transformed Tp53−/−, Cdk2−/− MEFs are resistant to Wee1 inhibition. (A) Four-day survival assay of Ras-V12-transformed Tp53−/−, Cdk2−/−, or Tp53−/− MEFs treated with MK-1775 (500 nM) or DMSO. After 4 d of treatment, cells were fixed, stained with crystal violet solution, and photographed. (B) Nontransformed Tp53−/−, Cdk2−/−, or Tp53−/− MEFs were grown in the presence of MK-1775 (500 nM) or DMSO. Relative cell viability was measured after 4 d by crystal violet quantification. Averages and SDs of two independent experiments are indicated.